Hydrochlorothiazide 25mg Transdermal Patch from Japan
Transdermal patch system delivering 25mg hydrochlorothiazide daily for steady diuretic effect. Qualifies under HTS 3004.90.92.62 explicitly including transdermal administration systems in measured doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Adhesion and flux rate validation needed
• Controlled release documentation for FDA
• Not for veterinary per human med classification